The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on Helicobacter pylori Eradication

OBJECTIVE: We evaluated the safety and efficacy of vonoprazan-based amoxicillin and clarithromycin 7-day triple therapy (VAC) in comparison to proton pump inhibitor (PPI)-based (PAC) as a first-line treatment and vonoprazan-based amoxicillin and metronidazole 7-day triple therapy (VAM) in comparison...

Descripción completa

Detalles Bibliográficos
Autores principales: Sue, Soichiro, Kuwashima, Hirofumi, Iwata, Yuri, Oka, Hiroyuki, Arima, Isao, Fukuchi, Takehide, Sanga, Katsuyuki, Inokuchi, Yasuhiro, Ishii, Yuniba, Kanno, Masatomo, Terada, Masahiro, Amano, Hitoshi, Naito, Makoto, Iwase, Shigeru, Okazaki, Hiroshi, Komatsu, Kazuto, Kokawa, Atsushi, Kawana, Ichiro, Morimoto, Manabu, Saito, Toshifumi, Kunishi, Yosuke, Ikeda, Akihiko, Takahashi, Daisuke, Miwa, Haruo, Sasaki, Tomohiko, Tamura, Toshihide, Kondo, Masaaki, Shibata, Wataru, Maeda, Shin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498188/
https://www.ncbi.nlm.nih.gov/pubmed/28566587
http://dx.doi.org/10.2169/internalmedicine.56.7833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498188/
https://www.ncbi.nlm.nih.gov/pubmed/28566587
http://dx.doi.org/10.2169/internalmedicine.56.7833

Ejemplares similares